Wikipedia

Tuberculous meningitis

Tuberculous meningitis, also known as TB meningitis or tubercular meningitis, is a specific type of bacterial meningitis caused by the Mycobacterium tuberculosis infection of the meninges—the system of membranes which envelop the central nervous system.[2][4]

Tuberculous meningitis
Other namesTB meningitis, Tubercular meningitis
CT scan showing tuberculous meningitis
SpecialtyNeurology Edit this on Wikidata
SymptomsFever[1]
CausesMycobacterium tuberculosis[2]
Diagnostic methodBlood culture, CT scan[2]
TreatmentAntibiotic therapy and corticosteroids[3]

Signs and symptoms

edit
See also: Chronic meningitis

Fever and headache are the cardinal features; confusion is a late feature and coma bears a poor prognosis. Meningism is absent in a fifth of patients with TB meningitis. Patients may also have focal neurological deficits.[1][5]

Causes

edit

Mycobacterium tuberculosis of the meninges is the cardinal feature and the inflammation is concentrated towards the base of the brain.[6] When the inflammation is in the brain stem subarachnoid area, cranial nerve roots may be affected. The symptoms will mimic those of space-occupying lesions.[7]

Blood-borne spread certainly occurs, presumably by crossing the blood–brain barrier, but a proportion of patients may get TB meningitis from rupture of a cortical focus in the brain;[8] an even smaller proportion get it from rupture of a bony focus in the spine.[9]

Pathophysiology

edit

The pathophysiology of tuberculous meningitis involves bacterial invasion of the brain parenchyma meninges or cortex, causing the formation of small subpial foci. These foci, termed Rich foci, are necrotic and expand as the colonies within them multiply. Tubercle (focal) rupture in the subarachnoid space causes meningitis.[3]

Diagnosis

edit
 
Tuberculous-meningitis-autopsy, showing associated brain oedema and congestion

Diagnosis of TB meningitis is made by analysing cerebrospinal fluid collected by lumbar puncture. When collecting CSF for suspected TB meningitis, a minimum of 1 ml of fluid should be taken (preferably 5 to 10 ml).[10][11] The CSF usually has a high protein, low glucose and a raised number of lymphocytes. Acid-fast bacilli are sometimes seen on a CSF smear, but more commonly, M. tuberculosis is grown in culture.[12] A spiderweb clot in the CSF that has been collected is rare but indicative of TB meningitis. ELISPOT testing is not useful for the diagnosis of acute TB meningitis and is often false negative,[13] but may paradoxically become positive after treatment has started, which helps to confirm the diagnosis.[citation needed]

Nucleic acid amplification tests (NAAT)

edit

This is a group of tests that use polymerase chain reaction (PCR) to detect mycobacterial nucleic acid.[14] These test vary in which nucleic acid sequence they detect and vary in their accuracy. The two most common commercially available tests are the amplified mycobacterium tuberculosis direct test (MTD, Gen-Probe) and Amplicor.[15] In 2007, review concluded that for diagnosing tuberculous meningitis "Individually, the AMTD test appears to perform the best (sensitivity 74% and specificity 98%)", they found the pooled prevalence of TB meningitis to be 29%.[16] The fully automated PCR test using the Cepheid GeneXpert system of the Xpert Ultra MTB/RIF has improved sensitivity of up to 77% in persons with HIV and TB meningitis.[17]

Treatment

edit
See also: Tuberculosis treatment

The treatment of TB meningitis is isoniazid, rifampicin, pyrazinamide and ethambutol for two months, followed by isoniazid and rifampicin alone for a further ten months.[18] Steroids help reduce the risk of death in those without HIV.[19] Steroids can be used in the first six weeks of treatment,[20] A few people may require immunomodulatory agents such as thalidomide.[21] Hydrocephalus occurs as a complication in about a third of people with TB meningitis. The addition of aspirin may reduce or delay mortality, possibly by reducing complications such as cerebral infarctions.[22][23][24]

References

edit
  1. ^ a b Harman RJ, Mason P (2002-01-01). Handbook of Pharmacy Healthcare: Diseases and Patient Advice. Pharmaceutical Press. p. 93. ISBN 9780853695073. Archived from the original on 2023-01-11. Retrieved 2020-11-07.
  2. ^ a b c "Meningitis - tuberculous: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Archived from the original on 2016-07-05. Retrieved 2015-06-02.
  3. ^ a b Gupta G, Taylor BE, Ramachandran TS (2018-05-23). Talavera F (ed.). "Tuberculous Meningitis: Background, Pathophysiology, Etiology". Medscape. Archived from the original on 2021-10-25. Retrieved 2015-11-08.
  4. ^ "Tuberculous Meningitis -- Medical Definition". www.medilexicon.com. Archived from the original on 2016-05-13. Retrieved 2015-06-02.
  5. ^ Leach RM (2010-06-11). Acute and Critical Care Medicine at a Glance. John Wiley & Sons. p. 101. ISBN 9781444327229.
  6. ^ Christodoulides M (2013). Meningitis: Cellular and Molecular Basis. CABI. p. 154. ISBN 9781780641621.
  7. ^ Robbins, Stanley L.; Kumar, Vinay; Cotran, Ramzi S., eds. (2010). Robbins and Cotran pathologic basis of disease (8 ed.). Philadelphia, PA: Saunders/Elsevier. p. 1301. ISBN 978-1-4160-3121-5. OCLC 212375916.
  8. ^ Nicoll JA, Bone I, Graham D (2006-11-24). Adams & Graham's Introduction to Neuropathology 3Ed. CRC Press. p. 127. ISBN 9780340811979. Archived from the original on 2023-01-11. Retrieved 2015-06-02.
  9. ^ Behera, D. (2010). Textbook of pulmonary medicine (2 ed.). New Delhi ; St. Louis (USA): Jaypee Brothers Medical Publishers. p. 505. ISBN 978-81-8448-749-7.
  10. ^ "Cerebral spinal fluid (CSF) collection". MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine. Archived from the original on 2015-06-29. Retrieved 2015-06-02.
  11. ^ Bahr, NC; Tugume, L; Rajasingham, R; Kiggundu, R; Williams, DA; Morawski, B; Alland, D; Meya, DB; Rhein, J; Boulware, DR (October 2015). "Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF". The International Journal of Tuberculosis and Lung Disease. 19 (10): 1209–15. doi:10.5588/ijtld.15.0253. PMC 4768484. PMID 26459535.
  12. ^ Irani DN (2008). Cerebrospinal Fluid in Clinical Practice. Elsevier Health Sciences. p. 196. ISBN 978-1416029083. Archived from the original on 2023-01-11. Retrieved 2015-06-02.
  13. ^ Gram-Positive Bacterial Infections: Advances in Research and Treatment: 2011 Edition. ScholarlyEditions. 2012-01-09. p. 77. ISBN 9781464929717. Archived from the original on 2023-01-11. Retrieved 2015-06-02.
  14. ^ Takahashi T, Tamura M, Takasu T (2012). "The PCR-Based Diagnosis of Central Nervous System Tuberculosis: Up to Date". Tuberculosis Research and Treatment. 2012: 831292. doi:10.1155/2012/831292. PMC 3359676. PMID 22666577.
  15. ^ "CDC |TB | ...the Uses of Nucleic Acid Amplification Tests for the Diagnosis of TB: Background". www.cdc.gov. Archived from the original on 2015-07-02. Retrieved 2015-06-02.
  16. ^ Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, et al. (January 2007). "A systematic review of rapid diagnostic tests for the detection of tuberculosis infection". Health Technology Assessment. 11 (3): 1–196. doi:10.3310/hta11030. PMID 17266837.
  17. ^ Cresswell, FV; Tugume, L; Bahr, NC; Kwizera, R; Bangdiwala, AS; Musubire, AK; Rutakingirwa, M; Kagimu, E; Nuwagira, E; Mpoza, E; Rhein, J; Williams, DA; Muzoora, C; Grint, D; Elliott, AM; Meya, DB; Boulware, DR; ASTRO-CM, team (March 2020). "Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study". The Lancet. Infectious Diseases. 20 (3): 308–317. doi:10.1016/S1473-3099(19)30550-X. PMC 7045085. PMID 31924549.
  18. ^ Barnett AH (2006). Diabetes: Best Practice & Research Compendium. Elsevier Health Sciences. p. 146. ISBN 978-0323044011. Archived from the original on 2023-01-11. Retrieved 2015-06-02.
  19. ^ Prasad K, Singh MB, Ryan H (April 2016). "Corticosteroids for managing tuberculous meningitis". The Cochrane Database of Systematic Reviews. 2016 (4): CD002244. doi:10.1002/14651858.cd002244.pub4. PMC 4916936. PMID 27121755.
  20. ^ Harrison J, Kulkarni K, Baguneid M, Prendergast B (2009). Oxford Handbook of Key Clinical Evidence. OUP Oxford. p. 336. ISBN 9780199234073. Archived from the original on 2023-01-11. Retrieved 2015-06-02.
  21. ^ Central Nervous System Bacterial Infections—Advances in Research and Treatment: 2012 Edition: ScholarlyBrief. ScholarlyEditions. 2012-12-26. p. 28. ISBN 9781481616232.
  22. ^ Rajshekhar V (2009). "Management of hydrocephalus in patients with tuberculous meningitis". Neurology India. 57 (4): 368–374. doi:10.4103/0028-3886.55572. hdl:1807/56411. PMID 19770534.
  23. ^ Meningitis: New Insights for the Healthcare Professional: 2011 Edition: ScholarlyBrief. ScholarlyEditions. 2012-01-09. p. 2. ISBN 9781464905292.
  24. ^ Di Bella S, Luzzati R, Principe L, Zerbato V, Meroni E, Giuffrè M, et al. (January 2022). "Aspirin and Infection: A Narrative Review". Biomedicines. 10 (2): 263. doi:10.3390/biomedicines10020263. PMC 8868581. PMID 35203473.
edit
 
Scholia has a topic profile for Tuberculous meningitis.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Tuberculous_meningitis&oldid=1242019461"